Skip to main content
OpenTrials

Clinical trial condition

Liver Diseases

Explore clinical trials studying Liver Diseases. Study availability and eligibility vary by location and protocol.

8,331 public trials 1,293 recruiting studies
Refine in advanced search Browse all conditions

Liver Diseases trial results

Active, Not Recruiting

Finite Versus Continuous Nucleos(t)Ide Analogues for Chronic Hepatitis B

NCT05793268

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations
  • Chia-Yi Christian Hospital Chiayi City, Taiwan
  • E-Da Hospital Kaohsiung City, Taiwan
  • Taichung Veterans General Hospital Taichung, Taiwan
  • Fu-Jen Catholic University Hospital Taipei, Taiwan
View Trial Details
Active, Not Recruiting

Prediction System of Clinical Endpoint Events for Chronic Hepatitis B Patients

NCT03777969

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +17 more
Locations
  • Beijing Ditan Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Beijing Friendship Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Nanfang Hospital, Southern Medical University Guangzhou, Guangdong, China
  • Wuxi Hisky Medical Technologies Co., Ltd. Wuxi, Jiangsu, China
View Trial Details
Active, Not Recruiting

Study of an Immunotherapeutic, DPX-Survivac, in Combination With Low Dose Cyclophosphamide & Pembrolizumab, in Subjects With Selected Advanced & Recurrent Solid Tumors

NCT03836352

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +39 more
Locations
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • Cedars Sinai Medical Center: Samuel Oschin Comprehensive Cancer Center Los Angeles, California, United States
  • Boca Raton Regional Hospital, Lynn Cancer Institute Boca Raton, Florida, United States
  • Hematology Oncology Associates of the Treasure Coast Port Saint Lucie, Florida, United States
View all 23 locations
View Trial Details
Active, Not Recruiting

Entecavir to TAF Switch

NCT03489239

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations
  • Thomas Jefferson University Philadelphia, Pennsylvania, United States
View Trial Details

Related conditions